TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06956014: Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

Sponsor: Vertanical GmbH · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 810 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$8,061,624

Rescue Site Savings

+$5,327,272

Unlock Full NCT06956014 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06956014 Rescue Dossier →